Smith Hunter C bought RYTM
February 11, 2026 · Form 4 insider transaction
Smith Hunter C bought 37,500 shares of Rhythm Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
37,500
Price
$0.00
Total value
N/A
InsiderSmith Hunter C
Role—
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2026
Filing dateFebruary 12, 2026
Shares owned after37,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options were granted on February 11, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.